Table 3.
Number of participants | Risk of dementia* | Risk of AD† | Risk of VaD† | Risk of OD† | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Control | Dementia | AD | VaD | OR | 95% CI | p | OR | 95% CI | p | OR | 95% CI | p | OR | 95% CI | p | |
Model 1‡ | ||||||||||||||||
None | 14674 | 767 | 531 | 144 | 1.00 | 1.00 | 1.00 | 1.00 | ||||||||
Parental | 1659 | 94 | 74 | 12 | 1.47 | 1.15–1.86 | 0.002 | 1.72 | 1.31–2.26 | <0.001 | 0.99 | 0.54–1.81 | 0.963 | 0.92 | 0.44–1.93 | 0.822 |
Model 2§ | ||||||||||||||||
None | 7938 | 358 | 245 | 63 | 1.00 | 1.00 | 1.00 | 1.00 | ||||||||
Parental | 1055 | 46 | 41 | 2 | 1.13 | 0.80–1.59 | 0.482 | 1.54 | 1.06–2.23 | 0.023 | 0.27 | 0.07–1.13 | 0.073 | 0.50 | 0.15–1.62 | 0.245 |
OR, odds ratio; CI, confidence intervals; AD, Alzheimer’s disease; VaD, Vascular dementia, OD; Other dementia
binary logistic regression analyses
multinomial logistic regression analyses
adjusted for age, educational level, hypertension, diabetes mellitus and cohort as covariates
adjusted for age, educational level, hypertension, diabetes mellitus, cohort and the presence of APOE ε4 allele as covariates